Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Ascending cholangitis

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Suspected infection in an obstructed biliary system is an emergency because antibiotics cannot replace drainage. Start ABCDE assessment, obtain blood cultures without delaying treatment, give prompt local-guideline intravenous antibiotics, restore perfusion with reassessed fluid boluses and contact senior endoscopy and hepatopancreatobiliary teams early for urgent biliary decompression.

Synopsis

Identify infected biliary obstruction before shock develops, deliver immediate sepsis treatment and coordinate urgent decompression while preserving a plan for the underlying cause.

  • Ascending cholangitis is infection within an obstructed biliary system; antibiotics penetrate an imperfectly drained source and therefore cannot replace decompression when obstruction persists.
  • Charcot's triad of right-upper-quadrant pain, fever and jaundice is memorable but incompletely sensitive; absence of one component must not reassure a deteriorating patient.
  • Hypotension and altered mental state added to the triad form Reynolds' pentad and signal advanced disease, not criteria to wait for before escalating.
  • Use ABCDE, obtain blood cultures promptly, measure lactate, give oxygen when indicated, restore perfusion carefully and start local-guideline intravenous antibiotics without unnecessary delay.
  • Contact the emergency endoscopy and senior hepatopancreatobiliary team early; source control is usually ERCP drainage, with percutaneous or surgical routes when endoscopy fails or anatomy prevents it.
  • Ultrasound, MRCP or CT can demonstrate obstruction, but a septic patient should not wait for a perfect duct map when clinical and biochemical evidence already supports urgent drainage.
  • Common causes include choledocholithiasis, malignant or benign stricture, blocked stent and postoperative anatomy; definitive treatment continues after the initial pus and pressure are relieved.
  • Older, frail, immunosuppressed and biliary-stented patients may present with delirium, falls, renal injury or unexplained sepsis rather than dramatic jaundice or local pain.

Key red flags

Septic shock phenotype

Hypotension, mottling, prolonged capillary refill, oliguria, rising lactate, hypoxaemia or confusion marks organ dysfunction and requires emergency senior and critical-care support.

Blocked stent presentation

Recurrent fever, pain or jaundice after biliary stenting should be treated as possible stent occlusion or migration until imaging and endoscopic review show otherwise.

Muted older presentation

Delirium, reduced intake, falls, acute kidney injury or functional collapse can dominate in older adults, with little abdominal guarding and only subtle jaundice.

Investigation priorities

01
Repeated physiological observationsFirst step

Detect evolving organ dysfunction and measure response to fluids, antimicrobials and biliary drainage.

Management branches

First hourSepsis and obstruction response

Biliary symptoms, inflammation and cholestasis occur with systemic illness or organ dysfunction.

  1. Start ABCDE, call senior help, give oxygen for hypoxaemia, establish intravenous access and monitor urine output and mental state.
  2. Obtain cultures and core blood tests promptly, then administer the locally recommended intravenous biliary-sepsis regimen with renal and allergy adjustment.
  3. Resuscitate hypoperfusion using repeated clinical reassessment, avoiding both inadequate restoration and unmonitored fluid overload in cardiac or renal vulnerability.
  4. Alert ERCP, HPB surgery, anaesthesia and critical care early, communicating suspected level, previous anatomy, anticoagulation and any existing stent.

Key medicines

Empiric intravenous cholangitis antibioticsAdminister the current trust biliary-sepsis regimen promptly at BNF doses, adjusting for kidney function, body size, allergy and resistant-organism history.Selection varies by local resistance and healthcare exposure; obtain cultures where immediate, review daily and never allow repeat dosing to postpone drainage.
Balanced or isotonic crystalloidGive protocol-sized intravenous boluses only for evidence of hypoperfusion, reassessing blood pressure, lungs, urine output, lactate and peripheral perfusion after each.Fixed large volumes can harm frail patients or those with heart, kidney or liver failure; shock refractory to cautious resuscitation needs critical-care vasopressors.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG188 gallstone disease recommendations
  • NICE NG253 suspected sepsis in people aged 16 or overCurrent adult sepsis risk assessment, prompt empirical treatment, reassessed fluid resuscitation, escalation and source-control framework.
  • BSG ERCP quality improvement programme
  • BNF piperacillin with tazobactam monograph

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom